In the realm of biochemical research and peptide science, few compounds have garnered as much attention as the bicyclic molecule known as depsipeptide. Often referred to in scientific literature by its designation FK228, also kno Romidepsin, also known as FK228 or depsipeptide,is potent and selective inhibitor of histone deacetylases (HDACs) which are associated with the regulation of Read more wn as depsipeptide, this compound represents a fascinating intersection of natural product chemistry and enzymatic regulation. As someone deeply interested in the structural nuances of peptide-based research, I have spent considerable time reviewing the molecular characteristics of this unique agent.
Understanding the Structural Complexity
At its core, FK228 is a bicyclic depsipeptide that stands apart from linear synthetic alternatives. The molecule features a complex 16-membered cyclic depsipeptide structure, which is integral to its biological behavior. When analyzing the depsipeptide HDAC landscape, it is important to recognize that this molecule acts as a natural prodrug. It requires intracellular reduction to become active, a mechanism that highlights its high degree of specificity.
Research consistently demonstrates that depsipeptide is a histone deacetylase inhibitor molecule of exceptional potency. Unlike broader agents, it is a potent and selective inhibitor of HDAC1 and HDAC2, which are crucial enzymes involved in the regulation of gene expression through chromatin remodeling.
Mechanism and Potency
The efficiency of this compound is well-documented. It is highly efficient in inhibiting the activity of HDACs, often functioning at nanomolar concentrations. My own observations of the available data suggest that depsipeptide has nanomolar inhibitory HDAC activity, which makes it a frequent subject for those studying the modulation of histone acetylation.
Furthermore, the histone deacetylase inhibitor (HDACi) profile of this compound is distinct. It is the only natural product histone deacetylase (HDAC) inhibitor that has undergone extensive evaluation in advanc by W Zhou·2009·Cited by 30—A novel and potent HDAC inhibitor, depsipeptide, also known as FK228 or FR901228,is highly efficient in inhibiting the activity of HDACseven Read more ed research settings. Because depsipeptide, an HDAC inhibitor, recruits p300 and p21 via p53 acetylation, it offers a sophisticated pathway for studying cell cycle arrest and protein signaling.
Key Characteristics at a Glance
When considering the utility of this compound in laboratory settings, several factors define its profile:
* Selectivity: It is known to inhibit class I HDACs with high affinity.
* Potency: It is widely considered among the most potent histone deacetylase (HDAC) inhibitors currently documented in biochemical databases.
* Dual Function: The First Biologically Active Synthetic Analogues of FK228 Beyond simple deacetylation, depsipeptide not only modulates histone deacetylation but also influences non-histone proteins, expanding its utility in molecular studies.
Research Context and Safety
It is important to note that histone deacetylase inhibitors (HDACi) are a broad Romidepsin, also known as FK228 or depsipeptide,is potent and selective inhibitor of histone deacetylases (HDACs) which are associated with the regulation of Read more field of study. While many compounds are being screened, the specific depsipeptide molecule stands out due to its origin Enhancement of HDAC-inhibitory Activity by Reduction of FK228.FK228 is a bicyclic depsipeptidethat is structurally distinct from other HDAC inhibitors.Read more as a bacterial natural product. In early investigative studies, it was found to be safe in humans during initial trials, though my focus remains strictly on the biochemical and structural properties of the peptide itself.
The exploration of HDAC2 inhibitors are members of a new class of agents that cont The HDAC inhibitor depsipeptide transactivates the p53/ inue to provide insight into how cells manage genetic expression. By focusing on depsipeptide, researchers can better understand the delicate balance of the epigenome. Whether you are looking at depsipeptide hdacinhibitors or broader depsipeptide hdacdrugs, the consensus remains that this compound is a foundational The Changing Face of HDAC Inhibitor Depsipeptide tool for those exploring the frontiers of peptide-based enzymatic modulation.
Final Thoughts
The study of HDAC (Histone Deacetylase) regulation remains a pillar of modern molecular biology. The Histone Deacetylase Inhibitor Depsipeptide remains a gold standard for researchers because by LP Wu·2008·Cited by 146—Here, we report that anHDAC inhibitor, depsipeptide, exhibited significant demethylating activity on the promoters of several genes, including p16, SALL3, and Read more it is potent and selective inhibitor of histone deacetylases (HDACs). As a novel inhibitor of class I HDAC, its unique bicyclic structure ensures it remains a subject of intense scientific scrutiny and a vital component in the library of any serious peptide enthusiast.